Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma
Clinical trial NCT07126678 · RECRUITING
Trial details
- NCT number
- NCT07126678
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2028-07-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.